Naveena Poudyal
Overview
Explore the profile of Naveena Poudyal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
4
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poudyal N, Subedi Y, Shakespear M, Grilley M, Takemoto J, Chang C
Bioorg Med Chem
. 2024 Oct;
114:117947.
PMID: 39418748
The World Health Organization (WHO) recognizes Candida albicans and Cryptococcus neoformans as the critical priority fungal pathogens for which therapeutic solutions are needed. Azole-based antifungal agents, including triazoles, diazoles, and...
2.
Freeman S, Catrow J, Cox J, Turano A, Rich M, Ihrig H, et al.
Comp Med
. 2024 Mar;
74(1):3-11.
PMID: 38532262
L-368,899 is a selective small-molecule oxytocin receptor (OXTR) antagonist originally developed in the 1990s to prevent preterm labor. Although its utility for that purpose was limited, L-368,899 is now one...
3.
Chang C, Poudyal N, Verdugo D, Pena F, Stehberg J, Retamal M
Biomolecules
. 2023 Mar;
13(3).
PMID: 36979346
Background: Connexins (Cxs) are proteins that help cells to communicate with the extracellular media and with the cytoplasm of neighboring cells. Despite their importance in several human physiological and pathological...
4.
Takemoto J, Altenberg G, Poudyal N, Subedi Y, Chang C
Front Microbiol
. 2022 Oct;
13:1000199.
PMID: 36212866
Widely-used -derived antibacterial aminoglycosides have encountered challenges because of antibiotic resistance and toxicity. Today, they are largely relegated to medicinal topical applications. However, chemical modification to amphiphilic aminoglycosides can revive...